Matches in Wikidata for { <http://www.wikidata.org/entity/Q64658559> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q64658559 description "assaig clínic" @default.
- Q64658559 description "clinical trial" @default.
- Q64658559 description "clinical trial" @default.
- Q64658559 description "clinical trial" @default.
- Q64658559 description "clinical trial" @default.
- Q64658559 description "ensaio clínico" @default.
- Q64658559 description "ensayo clínico" @default.
- Q64658559 description "ensayu clínicu" @default.
- Q64658559 description "essai clinique" @default.
- Q64658559 description "klinisch onderzoek" @default.
- Q64658559 description "клінічне випробування" @default.
- Q64658559 name "Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients" @default.
- Q64658559 type Item @default.
- Q64658559 label "Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients" @default.
- Q64658559 prefLabel "Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients" @default.
- Q64658559 P1050 Q64658559-75660EE3-CCE0-4B10-B522-2E63D1FC82F4 @default.
- Q64658559 P1132 Q64658559-B44D6B74-97FC-4671-8B6A-7ABC1A43E57B @default.
- Q64658559 P1476 Q64658559-0FE9FF26-1738-4144-88CC-3E2B53192DCD @default.
- Q64658559 P17 Q64658559-10D1A407-EFCB-4F41-8DB6-C3C4DF8E8878 @default.
- Q64658559 P17 Q64658559-165A49E3-D9E6-4EE0-B2D4-4AECDF389DF4 @default.
- Q64658559 P17 Q64658559-397204B4-F1E5-46DD-A809-3B2A917031FE @default.
- Q64658559 P17 Q64658559-49872FD6-7E00-4CC5-972E-EE2C197E3C8C @default.
- Q64658559 P17 Q64658559-628C0667-D093-454E-8C88-FAC4ECE275D5 @default.
- Q64658559 P17 Q64658559-AE0D862C-32AA-4953-9719-6F33A142659E @default.
- Q64658559 P17 Q64658559-B7032700-111C-4944-AEA2-C63BAAED3C0C @default.
- Q64658559 P17 Q64658559-C4BF95B3-75C4-4CCC-92C1-D02D3DCC51E8 @default.
- Q64658559 P17 Q64658559-E2BF5F58-FDA8-4CC3-B944-B4C6E3F4DD28 @default.
- Q64658559 P17 Q64658559-EA796FB5-16F3-4DB3-A4D4-C5F9FB98A52E @default.
- Q64658559 P17 Q64658559-FE26A1C5-35AA-4783-9C2D-C25B442A0AAF @default.
- Q64658559 P2899 Q64658559-EB4EE08A-D5D9-4C57-8CA5-3A1E7BB85AE4 @default.
- Q64658559 P3098 Q64658559-8698F2C7-6DCD-4492-A77E-35F06E6CDBDE @default.
- Q64658559 P31 Q64658559-89B75945-E2FB-437C-8FB9-FC863B2F5052 @default.
- Q64658559 P4844 Q64658559-351ECDCA-A2F7-4D56-AAA3-56DF625CBFA8 @default.
- Q64658559 P4844 Q64658559-D822FDA2-D88A-446F-9156-FCEB87CD5319 @default.
- Q64658559 P580 Q64658559-93B206FB-86DC-405B-912D-AB7F7FCC5E05 @default.
- Q64658559 P582 Q64658559-510D55CA-87FF-46E7-847D-33CBCC9C39C8 @default.
- Q64658559 P6099 Q64658559-C61946E8-CD93-45CB-A3C1-B314B69C9BF1 @default.
- Q64658559 P8363 Q64658559-CFBC35B4-3678-4933-87C8-2108E2A79ED9 @default.
- Q64658559 P1050 Q12206 @default.
- Q64658559 P1132 "+530" @default.
- Q64658559 P1476 "A 4-month, Randomized, Double-blind, Placebo- and Active-Controlled, Multi-centre, Parallel-Group Study, With an Optional 2-month Extension, to Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus Patients" @default.
- Q64658559 P17 Q145 @default.
- Q64658559 P17 Q183 @default.
- Q64658559 P17 Q211 @default.
- Q64658559 P17 Q218 @default.
- Q64658559 P17 Q28 @default.
- Q64658559 P17 Q298 @default.
- Q64658559 P17 Q34 @default.
- Q64658559 P17 Q36 @default.
- Q64658559 P17 Q37 @default.
- Q64658559 P17 Q419 @default.
- Q64658559 P17 Q96 @default.
- Q64658559 P2899 "+18" @default.
- Q64658559 P3098 "NCT01020123" @default.
- Q64658559 P31 Q30612 @default.
- Q64658559 P4844 Q19484 @default.
- Q64658559 P4844 Q3108899 @default.
- Q64658559 P580 "2009-10-01T00:00:00Z" @default.
- Q64658559 P582 "2011-02-01T00:00:00Z" @default.
- Q64658559 P6099 Q42824440 @default.
- Q64658559 P8363 Q78089383 @default.